Trial · NCT01968980
Registered outcomes29
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 20 of 29
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Percent Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) at Week 12 | Baseline, Week 12 | |
| Secondary | Percent Change From Baseline in Total Cholesterol (TC) at Week 12 | Baseline, Week 12 | |
| Secondary | Percent Change From Baseline in Non High Density Lipoprotein Cholesterol (Non HDL-C) at Week 12 | Baseline, Week 12 | |
| Secondary | Percent Change From Baseline in Apolipoprotein B (ApoB) at Week 12 | Baseline, Week 12 | |
| Secondary | Percent Change From Baseline in Lipoprotein (a) at Week 12 | Baseline, Week 12 | |
| Secondary | Percent Change From Baseline in High Density Lipoprotein Cholesterol (HDL-C) at Week 12 | Baseline, Week 12 | |
| Secondary | Percent Change From Baseline in Low Density Lipoprotein Cholesterol (LDL-C) at Week 24 and 52 | Baseline, Week 24, 52 | |
| Secondary | Percent Change From Baseline in Total Cholesterol (TC) at Week 24 and 52 | Baseline, Week 24, 52 | |
| Secondary | Percent Change From Baseline in Non High Density Lipoprotein Cholesterol (Non HDL-C) at Week 24 and 52 | Baseline, Week 24, 52 | |
| Secondary | Percent Change From Baseline in Apolipoprotein B (ApoB) at Week 24 and 52 | Baseline, Week 24, 52 | |
| Secondary | Percent Change From Baseline in Lipoprotein (a) at Week 24 and 52 | Baseline, Week 24, 52 | |
| Secondary | Percent Change From Baseline in High Density Lipoprotein Cholesterol (HDL-C) at Week 24 and 52 | Baseline, Week 24, 52 | |
| Secondary | Percent Change From Baseline in Triglycerides (TG) at Week 12, 24 and 52 | Baseline, Week 12, 24, 52 | |
| Secondary | Percent Change From Baseline in Apolipoprotein A-I (ApoA-I) at Week 12, 24 and 52 | Baseline, Week 12, 24, 52 | |
| Secondary | Percent Change From Baseline in Apolipoprotein A-II (ApoA-II) at Week 12, 24 and 52 | Baseline, Week 12, 24, 52 | |
| Secondary | Percent Change From Baseline in Very Low Density Lipoprotein Cholesterol (VLDL-C) at Week 12, 24 and 52 | Baseline, Week 12, 24, 52 | |
| Secondary | Absolute Change From Baseline in Low Density Lipoprotein (LDL-C) at Week 12 | Baseline, Week 12 | |
| Secondary | Absolute Change From Baseline in Total Cholesterol (TC) at Week 12 | Baseline, Week 12 | |
| Secondary | Absolute Change From Baseline in Non- High Density Lipoprotein Cholesterol (Non HDL-C) at Week 12 | Baseline, Week 12 | |
| Secondary | Absolute Change From Baseline in Apolipoprotein B (ApoB) at Week 12 | Baseline, Week 12 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01968980/registered